Focus on Patients

  1. Evolving Neurology And Neuroinflammation Therapies And Trials In 2025 6/5/2025

    Could 2025 be the year that advancements in brain health and increased funding for innovative therapies make a difference for neuroinflammation therapies and trials? Immunic CEO Daniel Vitt, Ph.D., discusses.

  2. Regeneron Trials Balance Quest For "Scientific Truth" With Patient Impact 6/3/2025

    Regeneron’s Andres Sirulnik, MD, Ph.D., discusses the importance of seeking "scientific truth" and an unwavering commitment to patient centricity in the context of the company’s hematology research.

  3. Why Sponsors Must Build Trials That Acknowledge All Patients' Needs 5/22/2025

    Servier Pharmaceuticals' Susan Pandya discusses how sponsors can translate a belief in patient centricity into action by creating more accessible, inclusive, and patient-friendly pathways to participation.

  4. Celebrating Clinical Trials Day, Part 1: Putting The Patient First 5/20/2025

    Celebrate Clinical Trials Day 2025 with these industry experts sharing their experiences and advice for putting the patient first.

  5. Listen Up, Pharma: C. diff Patient Advocate Shares Tips To Better Understand Patients 5/8/2025

    The Peggy Lillis Foundation CEO Christian John Lillis discusses his experience advocating for C. diff therapies, highlighting some successes as well as shortcomings in feeling heard.

  6. Caregiver Distress: The Hidden Burden Of Dementia With Lewy Bodies — And Why Measuring It Matters 5/7/2025

    Taking care of a loved one can be challenging. Cognition Therapeutic experts contend that caregivers’ distress levels must be evaluated to better understand the impact of dementia with Lewy bodies (DLB) on patients, families, and society.

  7. DEI Was Never the Problem, The Way Pharma Did It Was 5/5/2025

    Consultant Denise Bronner details pharma's strategic rollback of DEI initiatives, roles, and even departments and explains why well-meaning but misguided intentions enabled their demise.

  8. The Future of Glaucoma Therapy: Adaptive Trial Design and Patient-Centric Protocols 4/25/2025

    Perfuse Therapeutics' Sevgi Gurkan, MD, discusses the company’s use of functional and structural endpoints, exploratory biomarkers, adaptive trial design plans, and patient-centric protocol development.

  9. Promising Clinical Trial Updates Shared At The American Academy Of Neurology Conference 4/24/2025

    The 2025 American Academy of Neurology (AAN) conference in early April saw some promising clinical trial updates treating Guillain-Barre Syndrome and Huntington’s Disease, CIDP, and ALS.

  10. Racial Inequities In Medicine: The Consequences Of Historical Unethical Experimentation In Clinical Trials 4/22/2025

    In part two of this series on racial inequities in clinical research, the authors discuss the impact those trials have had on clinical research in the Black community, especially for women.